Related Experiment Videos
Classical Friedreich's ataxia and its genotype
J Martin1, L Martin, A Löfgren
1Department of Neurology, Born-Bunge Foundation and University of Antwerp, Belgium. jjmneuro@uia.ua.ac.be
European Neurology
|September 4, 1999
Summary
DNA testing confirms Friedreich
Area of Science:
- Neurogenetics
- Molecular Neurology
Background:
- Friedreich's ataxia (FRDA) is a rare inherited neurodegenerative disorder.
- Classical FRDA presents with characteristic clinical features.
- Genetic testing is crucial for definitive FRDA diagnosis.
Purpose of the Study:
- To evaluate the correlation between GAA repeat numbers and clinical presentation in FRDA patients.
- To assess the diagnostic value of clinical features versus genetic testing in FRDA.
Main Methods:
- Clinical examination of 14 FRDA patients with classical features.
- DNA investigation to quantify GAA repeats in the frataxin gene.
- Analysis of clinical data including age at onset, wheelchair dependence, and disease duration.
Main Results:
- All patients confirmed to have FRDA via DNA testing showing increased GAA repeats.
- No significant correlation found between GAA repeat number and disease severity or progression.
- Clinical features of FRDA remain characteristic and diagnostically valuable.
Conclusions:
- Genetic testing is essential for FRDA diagnosis, especially in idiopathic ataxias.
- Clinical presentation of FRDA is highly consistent, aiding diagnosis.
- GAA repeat expansion in the frataxin gene is the hallmark of FRDA.